Literature DB >> 8613414

Lowering body temperature with a cooling suit as symptomatic treatment for thermosensitive multiple sclerosis patients.

E Capello1, M Gardella, M Leandri, G Abbruzzese, C Minatel, A Tartaglione, M Battaglia, G L Mancardi.   

Abstract

A cooling system (Mark VII Microclimate System) was used to give six thermosensitive multiple sclerosis patients two 45-minute daily coolings for a period of one month. Before the first cooling, a baseline clinical and electrophysiological examination was performed. The same tests were repeated after the first application and after the thirtieth cooling day, thus providing information relating to acute and chronic efficacy. A clinical improvement was observed after both acute and, more unexpectedly, chronic cooling, whereas a significant improvement in central somatosensory conduction was recorded only under acute conditions. Our data suggest that cooling with this device leads to an improvement in some functional performances (mainly fatigue and strength) of about two hours' duration in thermosensitive patients.

Entities:  

Mesh:

Year:  1995        PMID: 8613414     DOI: 10.1007/bf02282911

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  14 in total

1.  Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis.

Authors:  C W WATSON
Journal:  N Engl J Med       Date:  1959-12-17       Impact factor: 91.245

2.  Use of cold applications in the management of spasticity; report of three cases.

Authors:  S W BASSETT; B M LAKE
Journal:  Phys Ther Rev       Date:  1958-05

3.  Electrophysiological detection of "silent" plaques in the optic pathways.

Authors:  A Tartaglione; A Oneto; F Bandini; L Spadavecchia; E Gandolfo; E Favale
Journal:  Acta Neurol Scand       Date:  1987-10       Impact factor: 3.209

4.  The effects of temperature on conduction in demyelinated single nerve fibers.

Authors:  M Rasminsky
Journal:  Arch Neurol       Date:  1973-05

5.  Symptom instability and thermoregulation in multiple sclerosis.

Authors:  C L Hopper; C G Matthews; C S Cleeland
Journal:  Neurology       Date:  1972-02       Impact factor: 9.910

6.  New subcortical components of the cerebral somatosensory evoked potential in man.

Authors:  M Abbruzzese; E Favale; M Leandri; S Ratto
Journal:  Acta Neurol Scand       Date:  1978-12       Impact factor: 3.209

7.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

8.  Method for quantitative estimation of thermal thresholds in patients.

Authors:  H Fruhstorfer; U Lindblom; W C Schmidt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

9.  Altered thermal sensitivity in injured and demyelinated nerve. A possible model of temperature effects in multiple sclerosis.

Authors:  F A Davis; S Jacobson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-10       Impact factor: 10.154

10.  Improvement in multiple sclerosis during prolonged induced hypothermia.

Authors:  G R Symington; I R Mackay; T T Currie
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  4 in total

Review 1.  Recommendations for physical activity in patients with multiple sclerosis.

Authors:  J H Petajan; A T White
Journal:  Sports Med       Date:  1999-03       Impact factor: 11.136

Review 2.  Thermoregulation in multiple sclerosis.

Authors:  Scott L Davis; Thad E Wilson; Andrea T White; Elliot M Frohman
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

3.  The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.

Authors:  Turan Poyraz; Egemen Idiman; Sezer Uysal; Leyla Iyilikci; Serkan Ozakbaş; Esra Coskuner Poyraz; Fethi Idiman
Journal:  ISRN Neurol       Date:  2013-05-16

Review 4.  Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations.

Authors:  Farzin Halabchi; Zahra Alizadeh; Mohammad Ali Sahraian; Maryam Abolhasani
Journal:  BMC Neurol       Date:  2017-09-16       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.